CIK 0001703647
- Non-accelerated filer
- Smaller reporting company
Korro Bio, Inc.
Sign in to watch- Ticker
- KRRO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472324450
- Phone
- +1 617-468-1999
- Business address
- 60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
- Former names
- Frequency Therapeutics, Inc.
- Open-market buys, last 90 days
- $884,752
- in 1 filing
- Open-market sales, last 90 days
- $1,763,410
- in 5 filings, $1.8M under 10b5-1 plans
Net −$878,658. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 5 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-10-06 | Loose Christopher R. Chief Scientific Officer | Sale | −8,000 | $19.46 | $156K | 111,782 |
| 2020-10-05 | Loose Christopher R. Chief Scientific Officer | Sale | −8,000 | $18.35 | $147K | 119,782 |
| 2020-10-02 | Loose Christopher R. Chief Scientific Officer | Sale | −8,000 | $18.92 | $151K | 127,782 |
| 2020-10-01 | Loose Christopher R. Chief Scientific Officer | Sale | −8,000 | $18.84 | $151K | 135,782 |
| 2020-10-01 | Lucchino David L. President and CEO | Sale | −10,838 | $18.87 | $205K | 360,106 |
| 2020-10-01 | Lucchino David L. President and CEO | Sale | −4,878 | $19.71 | $96K | 355,228 |
| 2020-09-23 | FELDMANN CYNTHIA L Director | Grant or award · Stock Option | +29,693 | $20.37 | $605K | 29,693 |
| 2020-09-23 | Loose Christopher R. Chief Scientific Officer | Sale | −1,870 | $20.51 | $38K | 146,412 |
| 2020-09-23 | Loose Christopher R. Chief Scientific Officer | Sale | −2,606 | $21.57 | $56K | 143,806 |
| 2020-09-23 | Loose Christopher R. Chief Scientific Officer | Sale | −24 | $22.43 | $538 | 143,782 |
| 2020-09-09 | Loose Christopher R. Chief Scientific Officer | Sale | −3,724 | $18.91 | $70K | 149,058 |
| 2020-09-09 | Loose Christopher R. Chief Scientific Officer | Sale | −776 | $19.26 | $15K | 148,282 |
| 2020-09-01 | Lucchino David L. President and CEO | Sale | −12,128 | $18.40 | $223K | 374,530 |
| 2020-09-01 | Lucchino David L. President and CEO | Sale | −3,586 | $19.05 | $68K | 370,944 |
| 2020-08-19 | Loose Christopher R. Chief Scientific Officer | Sale | −4,500 | $22.97 | $103K | 152,782 |
| 2020-08-05 | Loose Christopher R. Chief Scientific Officer | Sale | −4,442 | $21.21 | $94K | 157,340 |
| 2020-08-05 | Loose Christopher R. Chief Scientific Officer | Sale | −58 | $21.91 | $1K | 157,282 |
| 2020-08-03 | Lucchino David L. President and CEO | Sale | −15,714 | $21.63 | $340K | 386,658 |
| 2020-07-22 | Loose Christopher R. Chief Scientific Officer | Sale | −4,500 | $21.51 | $97K | 161,782 |
| 2020-07-20 | MARCUS JOEL S Director | Grant or award | +55,555 | $18.00 | $1000K | 1,011,730 |
Page 29 of 34 · 670 trades